raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:827

Stargardt disease

Synonyms: Fundus flavimaculatus · Stargardt 1

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive
Age of onset
Adolescent, Adult, Childhood, Elderly
Status
active

A rare ophthalmic disorder that is usually characterized by a progressive loss of central vision associated with irregular macular and perimacular yellow-white fundus flecks, and a so-called ''beaten bronze'' atrophic central macular lesion.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enStargardt diseaseFundus flavimaculatus · Stargardt 1
frMaladie de StargardtDystrophie maculaire flavimaculée · Fundus flavimaculatus · Stargardt 1
deStargardt-KrankheitFundus flavimaculatus · Stargardt Makuladystrophie
esEnfermedad de Stargardt= en
itMalattia di Stargardt= en
nlZiekte van Stargardt= en
ptDoença de StargardtFundo flavimaculatus
plChoroba StargardtaDno żółto-plamiste · Stargardt 1
csStargardtova nemoc= en
ukХвороба СтаргардтаОчне яблуко (Fundus flavimaculatus) · Старгардт 1
zhStargardt病眼底黄色斑点症
trStargardt hastalığıStargardt 1 · Fundus flavimakulatus

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM248200Evalidated
OMIM600110BTNTvalidated
OMIM603786BTNTvalidated
ICD-10H35.5NTBTinclusionvalidated
ICD-119B70NTBTindexvalidated
MONDO0019353Evalidated
MeSHD000080362Evalidated
UMLSC0271093Evalidated
GARD181Evalidated
MedDRA10062766Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

5 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CNGB3Candidate gene tested inNot yet assessedHGNC:2153ENSG000001702896050808q21.3cyclic nucleotide gated channel subunit beta 315712225[PMID]
PRPH2Candidate gene tested inNot yet assessedHGNC:9942ENSG000001126191796056p21.1peripherin 2
ABCA4Disease-causing germline mutation(s) inAssessedHGNC:34ENSG000001986916016911p22.1ATP binding cassette subfamily A member 420633576[PMID]
ELOVL4Disease-causing germline mutation(s) inAssessedHGNC:14415ENSG000001184026055126q14.1ELOVL fatty acid elongase 420633576[PMID]
PROM1Disease-causing germline mutation(s) inAssessedHGNC:9454ENSG000000070626043654p15.32prominin 118654668[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00013 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2018[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2023-09-08
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0007663Reduced visual acuity
Very frequent (99-80%)
HP:0000610Abnormal choroid morphologyDiagnostic criterion
HP:0000493Abnormal foveal morphology
HP:0008002Abnormality of macular pigmentation
HP:0000649Abnormality of visual evoked potentials
HP:0000603Central scotoma
HP:0000551Color vision defect
HP:0000608Macular degeneration
HP:0000662Nyctalopia
HP:0007704Paroxysmal involuntary eye movementsDiagnostic criterion
HP:0007722Retinal pigment epithelial atrophy
HP:0007814Retinal pigment epithelial mottling
HP:0030329Retinal thinning
Frequent (79-30%)
HP:0008059Aplasia/Hypoplasia of the macula
HP:0030786Photopsia
HP:0030500Yellow/white lesions of the maculaDiagnostic criterion

Run the differential on the 12 obligate / very frequent terms

Annotation source: 36508525[PMID]_27739528[PMID]_27491360[PMID]

7

Sources for this card